Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
New Mexico Cancer Research Alliance
All patients failing to enroll in a specific therapeutic research protocol using FDA approved drugs or CTMS accepted therapies will be screened for this study. Patients will be randomized (Patient own choice) to either standard of care described in the NCCN guidelines and published as peer-reviewed phase II or III studies which show an efficacy or to one of the arms of the protocol they fail to enroll in, as determined by the treating physician.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients must have a cancer requiring chemotherapy or radiotherapy
You may not be if
Inability to comply with study and/or follow-up procedures
Any contraindication per the FDA notice to the selected drugs
Pregnant (positive pregnancy test) or lactating. No effective means of contraception (men and women) in subjects of child-bearing potential
Clareo Health | Comparison of Standard of Care or Treatment on Protocol